SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer

被引:24
|
作者
Schaefer, Thorsten [1 ,2 ]
Steiner, Rebekah [2 ,3 ]
Lengerke, Claudia [1 ,2 ,4 ]
机构
[1] Univ Basel, Dept Biomed, Stem Cells & Hematopoiesis Lab, CH-4031 Basel, Switzerland
[2] Univ Hosp Basel, CH-4031 Basel, Switzerland
[3] Univ Basel, Dept Biomed, Immunol Lab, CH-4031 Basel, Switzerland
[4] Univ Hosp Tubingen, Internal Med 2, D-72076 Tubingen, Germany
关键词
SOX2; p53; PI3K; AKT signaling; stem cells; pluripotency; genome integrity; DNA maintenance; DNA damage response (DDR); transformation; cancer; DNA-DAMAGE RESPONSE; CELL SELF-RENEWAL; HEMATOPOIETIC STEM; MUTANT P53; TRANSCRIPTION FACTORS; SOMATIC-CELLS; TUMOR-SUPPRESSOR; STRESS DEFENSE; REPAIR DEFECTS; MOUSE;
D O I
10.3390/ijms21144902
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stemness and reprogramming involve transcriptional master regulators that suppress cell differentiation while promoting self-renewal. A distinguished example thereof is SOX2, a high mobility group (HMG)-box transcription factor (TF), whose subcellular localization and turnover regulation in embryonic, induced-pluripotent, and cancer stem cells (ESCs, iPSCs, and CSCs, respectively) is mediated by the PI3K/AKT/SOX2 axis, a stem cell-specific branch of the PI3K/AKT signaling pathway. Further effector functions associated with PI3K/AKT induction include cell cycle progression, cellular (mass) growth, and the suppression of apoptosis. Apoptosis, however, is a central element of DNA damage response (DDR), where it provides a default mechanism for cell clearance when DNA integrity cannot be maintained. A key player in DDR is tumor suppressor p53, which accumulates upon DNA-damage and is counter-balanced by PI3K/AKT enforced turnover. Accordingly, stemness sustaining SOX2 expression and p53-dependent DDR mechanisms show molecular-functional overlap in PI3K/AKT signaling. This constellation proves challenging for stem cells whose genomic integrity is a functional imperative for normative ontogenesis. Unresolved mutations in stem and early progenitor cells may in fact provoke transformation and cancer development. Such mechanisms are also particularly relevant for iPSCs, where genetic changes imposed through somatic cell reprogramming may promote DNA damage. The current review aims to summarize the latest advances in the understanding of PI3K/AKT/SOX2-driven stemness and its intertwined relations to p53-signaling in DDR under conditions of pluripotency, reprogramming, and transformation.
引用
收藏
页码:1 / 21
页数:21
相关论文
共 50 条
  • [1] SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond
    Thorsten Schaefer
    Claudia Lengerke
    Oncogene, 2020, 39 : 278 - 292
  • [2] SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond
    Schaefer, Thorsten
    Lengerke, Claudia
    ONCOGENE, 2020, 39 (02) : 278 - 292
  • [3] Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer
    Chun, Sang Hoon
    Jung, Chan-Kwon
    Won, Hye Sung
    Kang, Jin-Hyoung
    Kim, Yeon-Sil
    Kim, Min-Sik
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (05): : 636 - 643
  • [4] PI3K/Akt-mediated regulation of p53 in cancer
    Abraham, Aswin G.
    O'Neill, Eric
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 798 - 803
  • [5] MCAM modulates small cell lung cancer chemoresistance via PI3k/Akt/Sox2 signaling pathway
    Tripathi, Satyendra C.
    Fahrmann, Johannes F.
    Celiktas, Muge
    Aguilar, Mitzi
    Marini, Kieren D.
    Jolly, Mohit K.
    Katayama, Hiroyuki
    Wang, Hong
    Murage, Eunice N.
    Dennison, Jennifer B.
    Watkins, D. Neil
    Levine, Herbert
    Ostrin, Edwin J.
    Taguchi, Ayumu
    Hanash, Samir M.
    CANCER RESEARCH, 2017, 77
  • [6] The role of HM13 expression and its relationship to PI3K/Akt and p53 signaling pathways in colorectal cancer
    Jin, Xiao
    Wang, Hao
    Wang, Yong
    TISSUE & CELL, 2025, 93
  • [7] HBXIP Regulates Gastric Cancer Glucose Metabolism and Malignancy Through PI3K/AKT and p53 Signaling
    Qiu, Lei
    Lu, Feng
    Zhang, Lili
    Wang, Gang
    Geng, Rui
    Miao, Yongchang
    ONCOTARGETS AND THERAPY, 2020, 13 : 3359 - 3374
  • [8] Activated PI3K signaling as an endogenous inducer of p53 in human cancer
    Lee, Carolyn
    Kim, Jung-Sik
    Waldman, Todd
    CELL CYCLE, 2007, 6 (04) : 394 - 396
  • [9] An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
    Quan, Mei-Yu
    Guo, Qiang
    Liu, Jiayu
    Yang, Ruo
    Bai, Jing
    Wang, Wei
    Cai, Yaxin
    Han, Rui
    Lv, Yu-Qing
    Ding, Li
    Billadeau, Daniel D.
    Lou, Zhenkun
    Bellusci, Saverio
    Li, Xiaokun
    Zhang, Jin-San
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [10] MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway
    Tripathi, Satyendra C.
    Fahrmann, Johannes F.
    Celiktas, Muge
    Aguilar, Mitzi
    Marini, Kieren D.
    Jolly, Mohit K.
    Katayama, Hiroyuki
    Wang, Hong
    Murage, Eunice N.
    Dennison, Jennifer B.
    Watkins, D. Neil
    Levine, Herbert
    Ostrin, Edwin J.
    Taguchi, Ayumu
    Hanash, Samir M.
    CANCER RESEARCH, 2017, 77 (16) : 4414 - 4425